title: Preferential formation of deletions following in vivo exposure of postmeiotic Drosophila germ cells to the DNA etheno-adduct-forming carcinogen vinyl carbamate.
abstract: DNA sequence changes induced in the vermilion gene of Drosophila following in vivo treatment of postmeiotic male germ cells with vinyl carbamate (VCA), an etheno-adduct-forming carcinogen, are primarily deletions. With VCA, 65% (13/20) of the vermilion mutants isolated from crosses of NER+ (nucleotide excision repair) males with NER+ females and 40% (6/15) obtained from matings with NER- females were intra- or multi-locus deletions. Due to the insufficiently low mutagenic activity in NER+ genotypes of vinyl bromide (VB), another epsilon-adduct-forming carcinogen, vermilion mutants could only be isolated from crosses of VB-treated males with NER- females. Of 14 vermilion mutants induced by VB, three carried large deletions. Twenty-two of 23 base substitutions derived from either VCA or VB experiments fell into one of the four categories expected from epsilon-adducts: three vermilion mutants had GC-->AT transitions, five had AT-->GC transitions, 7 carried GC-->TA transversions, and 7 were AT-->TA transversions. In view of the similarities in the response of mouse and Drosophila germ lines to several classes of alkylating agents, a high incidence of deletions is predicted to occur as well in postmeiotic germ cells of mice exposed to these types of agents.
authors.affiliation: Medical Genetics Centre South-West Netherlands (MGC), Department of Radiation Genetics and Chemical Mutagenesis, Leiden University, The Netherlands.
authors.forename: L A
authors.initials: LA
authors.lastname: Ballering
authors.forename: M J
authors.initials: MJ
authors.lastname: Nivard
authors.forename: E W
authors.initials: EW
authors.lastname: Vogel
mesh_terms: D000818:Animals; D002273:Carcinogens / Q000494:pharmacology*; D004330:Drosophila / Q000235:genetics*; D005260:Female; D005500:Follow-Up Studies; D017353:Gene Deletion; D005819:Genetic Markers; D005854:Germ Cells / Q000187:drug effects*; D008297:Male; D009153:Mutagens / Q000494:pharmacology*; D014520:Urethane / Q000031:analogs & derivatives* / Q000494:pharmacology; D014752:Vinyl Chloride / Q000494:pharmacology
chemical_list: D002273:Carcinogens; D005819:Genetic Markers; D009153:Mutagens; D014520:Urethane; C017963:vinyl carbamate; D014752:Vinyl Chloride